|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00084188 |
Purpose
The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.
| Condition | Intervention | Phase |
|---|---|---|
|
Behavior Therapy |
Behavioral: Behavior Therapy |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs |
| Estimated Enrollment: | 541 |
| Study Start Date: | May 2004 |
| Study Completion Date: | October 2005 |
| Primary Completion Date: | October 2005 (Final data collection date for primary outcome measure) |
The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE).
This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.
Contacts and Locations| United States, California | |
| BAART CDP | |
| Los Angeles, California, United States, 90057 | |
| United States, Connecticut | |
| Hartford Dispensary | |
| New Britain, Connecticut, United States, 06051 | |
| United States, New York | |
| Staten Island University Hospital | |
| Staten Island, New York, United States, 10309 | |
| United States, North Carolina | |
| South Light - Wakeview | |
| Raleigh, North Carolina, United States, 27604 | |
| South Light - Life Plus | |
| Raleigh, North Carolina, United States, 27604 | |
| Addiction Drug Services | |
| Greensboro, North Carolina, United States, 27401 | |
| United States, Ohio | |
| Comprehensive Addiction Services System | |
| Toledo, Ohio, United States, 43620 | |
| United States, Pennsylvania | |
| The Consortium | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Thomas Jefferson Intensive Sub. Abuse TP | |
| Philadelphia, Pennsylvania, United States, 19107 | |
| United States, South Carolina | |
| LRADAC-Lexington-Richmond Alcohol & Drug Council | |
| Columbia, South Carolina, United States, 29204 | |
| United States, Washington | |
| Evergreen Treatment Services | |
| Seattle, Washington, United States, 98134 1618 | |
| United States, West Virginia | |
| Prestera Center for Mental Health Svcs. | |
| Huntington, West Virginia, United States, 25704 | |
| Principal Investigator: | Susan Tross, Ph.D. | New York State Psychiatric Institute |
More Information
| Study ID Numbers: | NIDA-CTN-0019-1 |
| Study First Received: | June 8, 2004 |
| Last Updated: | July 28, 2008 |
| ClinicalTrials.gov Identifier: | NCT00084188 |
| Health Authority: | United States: Federal Government |
|
HIV Infections Acquired Immunodeficiency Syndrome |
